Vaxart, Inc.

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet …

Biotechnology

US, South San Francisco [HQ]

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Officers & BofD Beta

All directors and officers of Vaxart, Inc. are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).

Form 3/4/5
Proxy DEF-14A

Total Compensation

Shows the total compensation per mentioned executive and board director.
Each datapoint refers the most recent appearance of the corresponding person.

- No data, only available if we have DEF 14A compensations in place -

Officers

Name & Position	Research
Lee Phillip E Chief Financial Officer	Transactions Compensations Speech	12/17/24 [Form 4]
Tucker Sean SVP, Chief Scientific Officer	Transactions Compensations Speech	04/01/24 [Form 4]
Cummings James F. Chief Medical Officer	Transactions Compensations Speech	04/01/24 [Form 4]
Berg Edward B SVP, General Counsel	Transactions Compensations Speech	03/20/24 [Form 4]
Lo Steven President, Chief Exec Officer Also inside the BofD	Transactions Compensations Speech	03/20/24 [Form 4]
Floroiu Cezar Andrei President, Chief Exec Officer Also inside the BofD	Transactions Compensations Speech	03/21/23 [Form 4]
Ahmad Fuad Interim CFO	Transactions Compensations Speech	06/23/22 [Form 4]

Board of Directors (BofD)

Name & Position	Research
Watson W. Mark Director	Transactions Compensations Speech	06/20/24 [Form 4]
Wheadon David E. Director	Transactions Compensations Speech	06/12/24 [Form 4]
Finney Michael J. Director	Transactions Compensations Speech	06/12/24 [Form 4]
Heron Elaine J Director	Transactions Compensations Speech	06/12/24 [Form 4]
Yedid Robert A. Director	Transactions Compensations Speech	06/12/24 [Form 4]
Davis Todd C Director	Transactions Compensations Speech	08/08/22 [Form 4]
Cherrington Julie M Director	Transactions Compensations Speech	08/08/22 [Form 4]